New hope for cancer patients: drug may prevent chemo weight loss
NCT ID NCT06998758
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether megestrol acetate, a drug that boosts appetite, can help patients with locally advanced colorectal cancer avoid weight loss during chemotherapy. About 60 adults will receive either the drug or a placebo alongside their standard treatment. The goal is to see if it improves appetite, nutrition, and treatment tolerance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Sixth Affiliated Hospital of Sun-Yat sen University
RECRUITINGGuangzhou, Guangdong, 510065, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can shedding pounds reboot the Heart's exercise engine?
- Can setting easier goals boost digital weight loss success?
- Could a simple diet beat metabolic syndrome? genes may hold the key
- Can losing weight change how your body burns fuel during exercise?
- Can popular Weight-Loss drugs alter breastmilk supply?
- Diaper duty gets smart: a changing pad that tracks Baby's weight, feeding, and sleep